ERIOS, the first R&D center on the uses of software in health, presents its first use cases

ERIOS, the first R&D center on the uses of software in health, presents its first use cases
ERIOS, the first R&D center on the uses of software in health, presents its first use cases

DSIH, Morgan Bourven , WEDNESDAY MAY 22, 2024

Dedalus and the Montpellier University Hospital presented the first concrete results from ERIOS (Research and Integration Area of ​​Digital Tools in Health), this Wednesday, May 22 during the SantExpo show. They concern the management of antibiotic therapy, the medico-administrative management of patients placed in isolation or restraint, and the perspectives of generative AI.

As a reminder, Dedalus, a major European operator in digital health, the Montpellier University Hospital and the University of Montpellier, launched in 2022 a research center dedicated to digital health users. This project brings together industry and health professionals to enable the co-construction and systematic evaluation of digital tools, according to a scientific methodology.

“The fruits of this work, born from the long collaboration between the Montpellier University Hospital and Dedalus, are beginning to arrive and will soon be integrated into the DxCare suite”welcomed Frédéric Vaillant, deputy general manager of Dedalus, during a presentation on the publisher’s stand (stands J59 & K59). “The objective is to involve users as early as possible in the development, whether they are health professionals, patients, or caregivers”recalled Jérôme Euvrard, director of digital health and cybersecurity at GHT Est-Hérault Sud-Aveyron.

The roadmap of ERIOS, a public-private consortium financed by France 2030, provides for the implementation of 12 co-design experiments over 3 years. Two years after its launch (but concretely one year after the start of work, the first year having been devoted to setting up the project), the first results are promising.

Isopsy, a medico-administrative management tool for therapeutic isolation

The first tool presented is called Isopsy, and aims to facilitate the medico-administrative management of the 28,000 people in therapeutic isolation in psychiatry in France, a process heavily supervised by article 17. “It involves supervising a very complex process, with very structured sequencing and deadlines to be respected, which requires the coordination of several actors with strong sequential interdependence”explained Loïc Fontaine, ERIOS project manager.

Resulting from the work of 200 people, the Isopsy tool is a dashboard (centered on the patient, on the center or the department) taking the form of a timeline detailing the next required actions. “In summary, it is a calendar which constantly calculates each link in the chain, so that the professional can, on a single screen, understand where the patient is, and can anticipate actions”summarized Loïc Fontaine.

AntibioViz, an antibiotic therapy management tool

While one in two patients in intensive care and one in four in medicine/surgery are under antibiotic therapy, the second tool presented aims to facilitate this management.

Resulting from 33 workshops, in which 52 people participated, including 17 infectious disease specialists, AntibioViz takes the form of a dashboard where several widgets appear: history of anti-infectives, inflammation and hemodynamics, microbiology, etc. “With Antibioviz, we worked on the ability to understand and correlate information with each other”explained Loïc Fontaine.

AntibioViz and Isopsy will be integrated into the next major update of DxCare, in June 2025, it has been announced.

Work on AI

The rapid arrival of AI has shaken up the world of health and encouraged ERIOS stakeholders to integrate it into the project. Two use cases were presented.

The first, entitled MedNote, is a reflection on how to capture and exploit medical notes in the era of generative AI. “It’s work on the abilities of actors to project themselves into the use of AI”, explained David Morquin, medical director of ERIOS. The prototype allows you to navigate through medical notes and use AI functionalities to, for example, generate a summary of the patient’s situation. “We want to see how users react to these tools, if they are useful, but also how to obtain trust and human guarantee”observes David Morquin.

At the same time, the second use case linked to AI, ERIOS-Assistant, is an experiment in the use of generative AI aimed at thinking about how these tools will be used in the future, how they can be tested on the field, with what method.

Other work is already underway, including dashboards for pain management and improvement of nursing transmissions. Generative AI could well play an important role!




PREV Gaza: four hostages freed in deadly raid
NEXT at what time and on which channel to watch the fight?